These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 18821062

  • 1. Green tea catechins inhibit angiogenesis through suppression of STAT3 activation.
    Leong H, Mathur PS, Greene GL.
    Breast Cancer Res Treat; 2009 Oct; 117(3):505-15. PubMed ID: 18821062
    [Abstract] [Full Text] [Related]

  • 2. Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule.
    Tang FY, Nguyen N, Meydani M.
    Int J Cancer; 2003 Oct 10; 106(6):871-8. PubMed ID: 12918064
    [Abstract] [Full Text] [Related]

  • 3. (-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis.
    Zhu BH, Zhan WH, Li ZR, Wang Z, He YL, Peng JS, Cai SR, Ma JP, Zhang CH.
    World J Gastroenterol; 2007 Feb 28; 13(8):1162-9. PubMed ID: 17451194
    [Abstract] [Full Text] [Related]

  • 4. A novel bisindole-PBD conjugate inhibits angiogenesis by regulating STAT3 and VEGF in breast cancer cells.
    Sarma P, Ramaiah MJ, Pal D, Bhadra U, Pal Bhadra M.
    Life Sci; 2016 Apr 15; 151():264-276. PubMed ID: 26979778
    [Abstract] [Full Text] [Related]

  • 5. Inhibitory effects of epigallocatechin-3 gallate, a polyphenol in green tea, on tumor-associated endothelial cells and endothelial progenitor cells.
    Ohga N, Hida K, Hida Y, Muraki C, Tsuchiya K, Matsuda K, Ohiro Y, Totsuka Y, Shindoh M.
    Cancer Sci; 2009 Oct 15; 100(10):1963-70. PubMed ID: 19650861
    [Abstract] [Full Text] [Related]

  • 6. (-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer.
    Zhu BH, Chen HY, Zhan WH, Wang CY, Cai SR, Wang Z, Zhang CH, He YL.
    World J Gastroenterol; 2011 May 14; 17(18):2315-25. PubMed ID: 21633597
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. LYR71, a derivative of trimeric resveratrol, inhibits tumorigenesis by blocking STAT3-mediated matrix metalloproteinase 9 expression.
    Kim JE, Kim HS, Shin YJ, Lee CS, Won C, Lee SA, Lee JW, Kim Y, Kang JS, Ye SK, Chung MH.
    Exp Mol Med; 2008 Oct 31; 40(5):514-22. PubMed ID: 18985009
    [Abstract] [Full Text] [Related]

  • 15. STAT3-targeting RNA interference inhibits pancreatic cancer angiogenesis in vitro and in vivo.
    Huang C, Jiang T, Zhu L, Liu J, Cao J, Huang KJ, Qiu ZJ.
    Int J Oncol; 2011 Jun 31; 38(6):1637-44. PubMed ID: 21479358
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases.
    Tang Y, Nakada MT, Kesavan P, McCabe F, Millar H, Rafferty P, Bugelski P, Yan L.
    Cancer Res; 2005 Apr 15; 65(8):3193-9. PubMed ID: 15833850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.